March 11, 2009 - With the joint development of the Ziehm NaviPort 3D interface, the medical technology manufacturing companies Ziehm Imaging and Stryker have succeeded in importing 2D and 3D C-arm image data into Stryker’s active infrared navigation systems.

March 11, 2009 - Results from the PROTECT I trial evaluating the feasibility and effectiveness of the Abiomed Inc. Impella 2.5 circulatory assist device in high-risk percutaneous coronary intervention (PCI) procedures were published in the February issue of the Journal of the American College of Cardiology (JACC).

March 11, 2009 – The use of common screening tests, such as the ankle brachial index (ABI), along with traditional risk scoring systems like the Framingham Risk Score, has the potential to prevent heart attacks in thousands of individuals who, based on their Framingham, are not originally thought to be at high risk, say researchers at the Society of Interventional Radiology's 34th Annual Scienti

March 10, 2009 - Abbott today launched the VOYAGER NC Coronary Dilatation Catheter, a next-generation balloon dilatation catheter with high-pressure capability designed to optimize the treatment of patients with coronary artery disease (CAD) during angioplasty procedures. VOYAGER NC is now available in the U.S., Europe and select countries in Asia and Latin America.

March 10, 2009 - Carotid artery stenting (CAS) has demonstrated outcomes consistent with the American Heart Association’s (AHA) long-established guidelines for treatment of patients who have blockages in their carotid arteries and are at risk for standard carotid surgery, according to an analysis of two large, prospective studies published online Friday in the journal Circulation: Cardiovascular

March 10, 2009 - Frost & Sullivan bestowed its 2009 North American Technology Innovation of the Year Award on ValveXchange Inc. for developing the innovative ValveXchange Heart Valve System. Based on a two-part bioprosthetic tissue valve, the patented system promises to mitigate the compromises between traditional mechanical and tissue heart valves while providing maximal patient benefits.

March 10, 2009 – As early detection increases for peripheral arterial disease (PAD) and more patients seek treatment, the U.S. market for peripheral vascular treatment will grow to an estimated $4.7 billion by 2015, according to iData Research, an international medical device & dental market research firm.